Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Oct;53(10):1356-1358.
doi: 10.1038/s41409-018-0211-8. Epub 2018 May 8.

Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease

Affiliations
Case Reports

Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease

Eric R Tkaczyk et al. Bone Marrow Transplant. 2018 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosures: None

Competing Interests

There is no competing financial interests in relation to the work described.

Figures

Figure 1.
Figure 1.
Example of 3D images, rater selections of erythematous area, and estimation of lesion produced by image processing, with corresponding average a*, area, and total redness (total a*).
Figure 2.
Figure 2.
a) Time evolution of size of erythematous area selected by six humans exhibited poor reproducibility (ICC=0.09, range: 0.00, 0.44). b) Total redness from the selections exhibited high reproducibility (ICC=0.85, range: 0.59, 0.97). c) Total redness normalized to day 0 (baseline) is shown for both individual humans (red dots) and algorithm with different thresholds (black dots – a* thresholds of 2.0, 2.9, 3.9, 5.0, 6.3, 8.0, 10.4, 14.6, corresponding to the 60th, 65th, 70th, 75th, 80th, 85th, 90th, 95th percentiles, respectively). No statistically significant difference is present between the average human (red line) and algorithm (black line) data (p=0.81). Treatments are shown by the colored boxes. Error bars in all panels represent standard deviations.

References

    1. Curtis LM, Grkovic L, Mitchell SA, Steinberg SM, Cowen EW, Datiles MB, et al. NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD. Bone Marrow Transplantation. 2014;49(12):1513–20. - PMC - PubMed
    1. Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation. 2015;21(6):984–99. - PMC - PubMed
    1. Mitchell SA, Jacobsohn D, Powers KET, Carpenter PA, Flowers ME, Cowen EW, et al. A Multicenter Pilot Evaluation of the National Institutes of Health Chronic Graft-versus-Host Disease (cGVHD) Therapeutic Response Measures: Feasibility, Interrater Reliability, and Minimum Detectable Change. Biology of Blood and Marrow Transplantation. 2011;17(11):1619–29. - PMC - PubMed
    1. Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation. 2015;21(6):984–99. - PMC - PubMed
    1. Raina A, Hennessy R, Rains M, Allred J, Diven D, Markey MK. Objective measurement of erythema in psoriasis using digital color photography with color calibration. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2014; - PubMed